Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.

Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.

Item
http://www.wikidata.org/entity/Q39007364
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies.Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.Immune Checkpoint Blockade in Breast Cancer Therapy.MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.Cationic polymers for non-viral gene delivery to human T cells.Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy.Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy
P2860

Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.

Item
http://www.wikidata.org/entity/Q39007364
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Chimeric Antigen Receptor (CAR ...... f CD19 in B-Cell Malignancies.
@en
Chimeric Antigen Receptor
@nl
type
label
Chimeric Antigen Receptor (CAR ...... f CD19 in B-Cell Malignancies.
@en
Chimeric Antigen Receptor
@nl
prefLabel
Chimeric Antigen Receptor (CAR ...... f CD19 in B-Cell Malignancies.
@en
Chimeric Antigen Receptor
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Chimeric Antigen Receptor (CAR ...... of CD19 in B-Cell Malignancies
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P932